Back to Results
First PageMeta Content
Pharmaceutical sciences / Food and Drug Administration / Clinical research / Pharmaceutical industry / Drug safety / Expanded access / Investigational New Drug / Clinical trial / Health Insurance Portability and Accountability Act / Pharmacology / Health / Research


Emory IRB Guidance for Investigators Guidance for the IRB Submission of an Expanded Access IND (Treatment or Emergency use) of an Unapproved Drug The guidance below is for use of an unapproved drug to treat a patient or
Add to Reading List

Document Date: 2015-02-04 16:48:22


Open Document

File Size: 408,88 KB

Share Result on Facebook
UPDATE